Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Genetics

• Publication date

  2015-03-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng.3246PMID 25807283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

  2013cited by this paper
• Deletion of Abca7 Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease

  2013cited by this paper
• ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status.

  2013cited by this paper
• Elucidation of the BACE1 Regulating Factor GGA3 in Alzheimer's Disease

  2013cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013cited by this paper
• Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits

  2013cited by this paper
• Variant of TREM2 associated with the risk of Alzheimer's disease.

  2013cited by this paper
• Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.

  2013cited by this paper
• Novel late-onset Alzheimer disease loci variants associate with brain gene expression

  2012cited by this paper
• Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases

  2012cited by this paper
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012cited by this paper
• Rare-variant association testing for sequencing data with the sequence kernel association test.

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Role of ATP‐binding cassette transporters in brain lipid transport and neurological disease

  2008cited by this paper
• Detection of sharing by descent, long-range phasing and haplotype imputation

  2008cited by this paper
• Neurology®

  2007cited by this paper
• Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).

  2006cited by this paper
• ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages

  2006cited by this paper
• ABCA7 expression is regulated by cellular cholesterol through the SREBP2 pathway and associated with phagocytosis Published, JLR Papers in Press, June 20, 2006.

  2006cited by this paper
• Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease

  2006cited by this paper
• Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2

  2005cited by this paper
• Abca7 Null Mice Retain Normal Macrophage Phosphatidylcholine and Cholesterol Efflux Activity despite Alterations in Adipose Mass and Serum Cholesterol Levels*

  2005cited by this paper
• Human ABCA7 Supports Apolipoprotein-mediated Release of Cellular Cholesterol and Phospholipid to Generate High Density Lipoprotein*

  2004cited by this paper
• ATP-binding Cassette Transporter A7 (ABCA7) Binds Apolipoprotein A-I and Mediates Cellular Phospholipid but Not Cholesterol Efflux*

  2003cited by this paper
• Genomic Control for Association Studies

  1999cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Biometrics

  1914cited by this paper
• Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor

  year unknowncited by this paper

• Rare ABCA7 mutations in Alzheimer's disease and cerebral amyloid angiopathy pathology.

  2026cites this paper
• Artificial intelligence in drug development for delirium and Alzheimer’s disease

  2025cites this paper
• Revealing the nervous system requirements of Alzheimer disease risk genes in Drosophila.

  2025cites this paper
• Genetic risk for neurodegenerative conditions is linked to disease-specific microglial pathways

  2025cites this paper
• Structural variation detection and association analysis of whole‐genome‐sequence data from 16,543 Alzheimer's disease sequencing project subjects

  2025cites this paper
• Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research

  2025cites this paper
• Multi-ancestry exome-wide study identifies variants associated with Alzheimer's disease protection

  2025cites this paper
• The impact of rare genetic variants on Alzheimer disease

  2025cites this paper
• Alzheimer’s disease risk ABCA7 p.A696S variant disturbs the microglial response to amyloid pathology in mice

  2025influential citation
• Protective genetic variants against Alzheimer's disease.

  2025cites this paper
• Neuronal ABCA7 deficiency aggravates mitochondrial dysfunction and neurodegeneration in Alzheimer's disease

  2025cites this paper
• Single-nucleus and spatial transcriptomic profiling of human temporal cortex and white matter reveals key associations with AD pathology

  2025cites this paper
• Generation of an Inducible Destabilized‐Domain Cre Mouse Line to Target Disease Associated Microglia

  2025cites this paper
• Revealing the nervous system requirements of Alzheimer’s disease risk genes in Drosophila

  2025cites this paper
• ABCA7 variants impact phosphatidylcholine and mitochondria in neurons

  2025cites this paper
• Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development.

  2024cites this paper
• Extremely rare CNVs contributing to Alzheimer disease risk: a case-control association analysis of exome sequencing data from 22,319 individuals

  2024influential citation
• Increased burden of rare protein‐truncating variants in constrained, brain‐specific and synaptic genes in extremely impulsively violent males with antisocial personality disorder

  2024cites this paper
• The Abca7V1613M variant reduces Aβ generation, plaque load, and neuronal damage

  2024cites this paper
• A comparative study of structural variant calling in WGS from Alzheimer’s disease families

  2024cites this paper
• Single-nucleus and spatial transcriptomic profiling of human temporal cortex and white matter reveals novel associations with AD pathology

  2024cites this paper
• Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics

  2024cites this paper
• Lessons from genetic studies in Alzheimer disease.

  2024cites this paper
• ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling

  2024cites this paper
• Genomic stress and impaired DNA repair in Alzheimer disease.

  2024cites this paper
• The ABC's of Alzheimer risk gene ABCA7

  2024cites this paper
• Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer’s disease mouse model

  2024cites this paper
• Sex differences in DNA methylation variations according to ART conception-evidence from the Norwegian mother, father, and child cohort study

  2024cites this paper
• Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System

  2024cites this paper
• Recent advances in Alzheimer disease genetics

  2024cites this paper
• Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies

  2024cites this paper
• Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer’s Disease by Bioinformatics Analysis

  2024cites this paper
• Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia

  2024cites this paper
• Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening.

  2024cites this paper
• Advances in Gene Therapy Approaches Targeting Neuro-inflammation in Neurodegenerative Diseases.

  2024cites this paper
• Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approaches

  2024cites this paper
• Mass spectrometry imaging highlights dynamic patterns of lipid co‐expression with Aβ plaques in mouse and human brains

  2024cites this paper
• ABCA7 Loss-of-Function Variants Impact Phosphatidylcholine Metabolism in the Human Brain

  2024cites this paper
• Structural Variation Detection and Association Analysis of Whole-Genome-Sequence Data from 16,905 Alzheimer’s Diseases Sequencing Project Subjects

  2023cites this paper
• Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?

  2023cites this paper
• Structural Variation Detection and Association Analysis of Whole-Genome-Sequence Data from 16,905 Alzheimer’s Diseases Sequencing Project Subjects

  2023cites this paper
• Long-read transcript sequencing identifies differential isoform expression in the entorhinal cortex in a transgenic model of tau pathology

  2023cites this paper
• High-Quality Sleep Mitigates ABCA7-Related Generalization Deficits in Healthy Older African Americans

  2023cites this paper
• Fundamental neurochemistry review: Old brain stories ‐ Influence of age and sex on the neurodegeneration‐associated lipid changes

  2023cites this paper
• Functional variants identify sex-specific genes and pathways in Alzheimer’s Disease

  2023cites this paper
• ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases

  2023cites this paper
• RNA-based translation activators for targeted gene upregulation

  2023cites this paper
• Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease

  2023cites this paper
• The neuroimmune axis of Alzheimer’s disease

  2023cites this paper
• Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies

  2023cites this paper
• Alzheimer’s genes in microglia: a risk worth investigating

  2023cites this paper
• Chronic effects of inflammation on tauopathies.

  2023cites this paper
• CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response

  2023cites this paper
• Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease

  2023cites this paper
• A human mitofusin 2 mutation can cause mitophagic cardiomyopathy

  2023cites this paper
• Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies

  2023cites this paper
• Génétique de la maladie d’Alzheimer

  2022cites this paper
• Rare missense mutations in ABCA7 might increase Alzheimer’s disease risk by plasma membrane exclusion

  2022cites this paper
• The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease

  2022cites this paper
• A Systematic Analysis on the Genes and Their Interaction Underlying the Comorbidity of Alzheimer's Disease and Major Depressive Disorder

  2022cites this paper
• Remembering your A, B, C's: Alzheimer's disease and ABCA1

  2022cites this paper
• Sex-specific lipid dysregulation in the Abca7 knockout mouse brain

  2022cites this paper
• A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

  2022influential citation
• Clinical Deep Phenotyping of ABCA7 Mutation Carriers

  2022influential citation
• Balancing cholesterol in the brain: from synthesis to disposal

  2022cites this paper
• A comparative study of structural variant calling strategies using the Alzheimer’s Disease Sequencing Project’s whole genome family data

  2022cites this paper
• Associations of risk genes with onset age and plasma biomarkers of Alzheimer’s disease: a large case–control study in mainland China

  2022cites this paper
• ABCA7, a Genetic Risk Factor Associated with Alzheimer’s Disease Risk in African Americans

  2022cites this paper
• Vascular endothelial cells: a fundamental approach for brain waste clearance.

  2022cites this paper
• SNP-by-CpG Site Interactions in ABCA7 Are Associated with Cognition in Older African Americans

  2022cites this paper
• A human mitofusin 2 mutation causes mitophagic cardiomyopathy

  2022cites this paper
• ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions

  2022cites this paper
• Genetica della malattia di Alzheimer

  2022cites this paper
• Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer’s Disease in Nordic Populations

  2022cites this paper
• ATP-binding cassette protein ABCA7 deficiency impairs sphingomyelin synthesis, cognitive discrimination, and synaptic plasticity in the entorhinal cortex

  2022influential citation
• Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease

  2022cites this paper
• Microglial efferocytosis: Diving into the Alzheimer's disease gene pool.

  2022cites this paper
• A common haplotype lowers SPI1 expression in myeloid cells and delays age at onset for Alzheimer’s disease of Alzheimer's Alzheimer's Disease Neuroimaging Initiative

  2022cites this paper
• Genetics of Alzheimer Disease

  2022cites this paper
• Cohort profile: the Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog) – a national research and quality registry with a biomaterial collection

  2022cites this paper
• Generation of a homozygous ABCA7-knockout human iPSC line using the CRISPR/Cas9 system.

  2022cites this paper
• Analysis of Genetic Association Between ABCA7 Polymorphism and Alzheimer’s Disease Risk in the Southern Chinese Population

  2022cites this paper
• How wide is the application of genetic big data in biomedicine.

  2021cites this paper
• Strategies to gain novel Alzheimer’s disease diagnostics and therapeutics using modulators of ABCA transporters

  2021cites this paper
• Microglia‐specific ApoE knock‐out does not alter Alzheimer's disease plaque pathogenesis or gene expression

  2021cites this paper
• Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics

  2021cites this paper
• A reference induced pluripotent stem cell line for large-scale collaborative studies

  2021cites this paper
• The Amyloid-β Pathway in Alzheimer’s Disease

  2021cites this paper
• Clinico-genetic findings in 509 frontotemporal dementia patients

  2021cites this paper
• Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer’s disease risk

  2021cites this paper
• Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

  2021cites this paper
• Network-based analysis on genetic variants reveals the immunological mechanism underlying Alzheimer’s disease

  2021cites this paper
• ABCA7 Regulates Brain Fatty Acid Metabolism During LPS-Induced Acute Inflammation

  2021cites this paper
• Genomics and Functional Genomics of Alzheimer’s Disease

  2021cites this paper
• Premature termination codon mutations in ABCA7 contribute to Alzheimer's disease risk in Belgian patients.

  2021cites this paper
• Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes

  2021cites this paper
• Animal and Cellular Models of Alzheimer’s Disease: Progress, Promise, and Future Approaches

  2021cites this paper
• Late-in-life neurodegeneration after chronic sleep loss in young adult mice

  2021cites this paper
• Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review

  2021cites this paper
• Effect of memantine, an anti-Alzheimer’s drug, on rodent microglial cells in vitro

  2021cites this paper